Navamya Acharya

Investing.com -- AstraZeneca's (ST:AZN) rare disease unit Alexion (NASDAQ:ALXN) said its experimental drug anselamimab failed to meet the main goal in a major late-stage trial for...

Investing.com -- Shares of Handelsbanken (ST:SHBa) fell more than 7% on Wednesday after the Swedish lender reported a 12% drop in second-quarter operating profit to SEK 7.16...

Investing.com -- Bakkafrost (OL:BAKKA) shares sank over 14% on Wednesday after the salmon farmer reported a first-quarter loss and flagged continued pressure on margins from lower...

Investing.com -- ASML (AS:ASML) on Wednesday said it can no longer confirm revenue growth in 2026, citing increased macroeconomic uncertainty, marking a shift from earlier...

Investing.com -- SEB (ST:SEBa) on Wednesday reported a net profit of SEK 8.25 billion for the second quarter of 2025, 7% above consensus estimates of SEK 7.68 billion, driven by...

Investing.com -- Compagnie Financière Richemont SA (SIX:CFR), the Swiss parent of Cartier and Van Cleef & Arpels, posted €5.41 billion in revenue for the first quarter ended...

Investing.com -- Aker ASA’s net asset value rose to NOK 66.5 billion in the first half of 2025, up from NOK 58.2 billion at year-end, with NAV per share increasing to NOK 895 from...

Investing.com -- J.P. Morgan has named AngloGold Ashanti its top pick among EMEA gold miners, replacing Fresnillo (LON:FRES), as cost pressures and operational disruptions...